(2.3) Dosage Forms and Strengths Injection (3): o 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL, or 7.2 mg/0.75 mL (WEGOVY HD) in a single-dose pen o 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, or 2.4 mg/0.75 mL in a single-dose syringe o 9.6 mg/3 mL (3.2 mg/mL) solution in a single-patient-use pen (WEGOVY FlexTouch) that delivers four 2.4 mg/0.75 mL doses Tablets: 1.5 mg, 4 mg, 9 mg and 25 mg (3) Contraindications Warnings and Precautions Acute Pancreatitis: Has been observed in patients treated with GLP-1 receptor agonists, including WEGOVY
While its etiology remains unclear, many patients require ventriculoperitoneal shunting (VPS) for symptoms
Chat, which is a bit of a misnomer, is not staffed by a human or an AI
However, taking your injection on the same day each week helps establish a reliable routine and prevents accidental missed doses that could interrupt your weight loss progress
10.1002/dmrr.2502 122
Jing F, Zou Q, Pu Y (2023) GLP-1R agonist liraglutide attenuates pain hypersensitivity by stimulating IL-10 release in a nitroglycerin-induced chronic migraine mouse model